British Hospital Develops New Patient Selection Tool for Mesothelioma Clinical Trials, According to Surviving Mesothelioma

Choosing Mesothelioma Clinical Trial Candidates

The m-RPS is a useful tool to assess MM patient suitability for phase I trials…

Researchers in London have just released their findings on a new prognostic tool designed to help them select mesothelioma patients for Phase I clinical trials. Surviving Mesothelioma has just posted an article on the new tool. Click here to read it now.

Scientists at the Royal Marsden Hospital analyzed the cases of 65 mesothelioma patients who participated in Phase I clinical trials between 2003 and 2015.

According to their report in the European Journal of Cancer, mesothelioma patients who scored a one on a…

Read the full article from the Source…

Back to Top